Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May 15;23(10):2860-2.
doi: 10.1016/j.bmcl.2013.03.111. Epub 2013 Apr 4.

Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands

Affiliations

Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands

Prabhakar R Polepally et al. Bioorg Med Chem Lett. .

Abstract

Salvinorin A, the active ingredient of the hallucinogenic plant Salvia divinorum is the most potent known naturally occurring hallucinogen and is a selective κ-opioid receptor agonist. To better understand the ligand-receptor interactions, a series of dicarboxylic ester-type of salvinorin A derivatives were synthesized and evaluated for their binding affinity at κ-, δ- and μ-opioid receptors. Most of the analogues show high affinity to the κ-opioid receptor. Methyl malonyl derivative 4 shows the highest binding affinity (Ki=2nM), analogues 5, 7, and 14 exhibit significant affinity for the κ-receptor (Ki=21, 36 and 39nM).

PubMed Disclaimer

Figures

Figure 1
Figure 1
The structures of salvinorin A, 22-thiocyanatosalvinorin A, and salvinorin B.
Scheme 1
Scheme 1
Synthesis of dicarboxylic ester-type salvinorin A analogues 4-12 Reagents and conditions: (a) appropriate acid chloride, Et3N, dry DCM, N2 r.t, 2-3 h, or appropriate acid anhydride, DBU, dry DCM, N2, r.t, 6-8 h.
Scheme 2
Scheme 2
Synthetic route for the designed ligands 13-16. Reagents and conditions: (a) appropriate acid chloride, Et3N, dry DCM, N2, r.t, 3 h, or appropriate acid anhydride, DBU, dry DCM, N2, r.t, 6-8 h.

Similar articles

Cited by

References

    1. Ortega A, Blount JF, Manchand PS. J. Chem. Soc., Perkin Trans.1. 1982:2505–2508.
    1. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB. Proc. Natl. Acad. Sci. U.S.A. 2002;99:11934–11939. - PMC - PubMed
    1. Beguin C, Potuzak J, Xu W, Liu - Chen LY, Streicher JM, Groer CE, Bohn LM, Carlezon WA, Jr., Cohen BM. Bioorg. Med. Chem. Lett. 2012;22:1023–1026. - PMC - PubMed
    2. Lovell KM, Vasiljevik T, Araya JJ, Lozama A, Prevatt-Smith KM, Day VW, Dersch CM, Rothman RB, Butelman ER, Kreek MJ, Prisinzano TE. Bioorg. Med. Chem. 2012;20:3100–3110. - PMC - PubMed
    3. Cunningham CW, Rothman RB, Prisinzano TE. Pharmacol. Rev. 2011;63:316–347. - PMC - PubMed
    4. Lozama A, Cunningham CW, Caspers MJ, Douglas JT, Dersch CM, Rothman RB, Prisinzano TE. J. Nat. Prod. 2011;74:718–726. - PMC - PubMed
    5. Tidgewell K, Harding WW, Lozama A, Cobb H, Shah K, Kannan P, Dersch CM, Parrish D, Deschamps JR, Rothman RB, Prisinzano TE. J. Nat. Prod. 2006;69:914–918. - PubMed
    6. Bikbulatov RV, Yan F, Roth BL, Zjawiony JK. Bioorg. Med. Chem. Lett. 2007;17:2229–2232. - PMC - PubMed
    7. Lee DY, He M, Liu-Chen L-Y, Wang Y, Li J-G, Xu W, Ma Z, Carlezon WA, Jr., Cohen B. Bioorg. Med. Chem. Lett. 2006;16:5498–5502. - PubMed
    8. Stewart DJ, Fahmy H, Roth BL, Yan F, Zjawiony JK. Arzneimittelforschung. 2006;56:269–275. - PubMed
    9. Beguin C, Richards MR, Li JG, Wang Y, Xu W, Liu - Chen LY, Carlezon WA, Jr., Cohen BM. Bioorg. Med. Chem. Lett. 2006;16:4679–4685. - PubMed
    10. Harding WW, Tidgewell K, Byrd N, Cobb H, Dersch CM, Butelman ER, Rothman RB, Prisinzano TE. J. Med. Chem. 2005;48:4765–4771. - PubMed
    11. Lee DY, Yang L, Xu W, Deng G, Guo L, Liu-Chen LY. Bioorg. Med. Chem. Lett. 2010;20:5749–5752. - PMC - PubMed
    1. Yan F, Bikbulatov RV, Mocanu V, Dicheva N, Parker CE, Westel WC, Mosier PD, Westkaemper RB, Allen JA, Zjawiony JK, Roth BL. Biochem. 2009;48:6898–6908. - PMC - PubMed
    1. Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC. Nature. 2012;485:327–332. - PMC - PubMed

Publication types

MeSH terms